Sagimet Biosciences Inc. Series A Common Stock (SGMT) stock news · $403.2M cap
Sagimet Biosciences Inc. Series A Common Stock (SGMT) is a biotechnology company listed on NASDAQ.
This SGMT news page leads with what Sagimet Biosciences Inc. Series A Common Stock filed — not a scraped headline mill.
No cached 8-K sentence for SGMT yet. We will not pad this page with generic market recap.
Latest reported SGMT revenue for 2023-09-30 was $2.0M. Net income was -$6.4M. Revenue was up 0.0% from 2023-07-31 to 2023-09-30. SGMT currently screens at market cap $403.2M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the SGMT stock page; for the tape open the quote page.
SGMT stock news FAQ
What are SGMT's latest revenue and net income?
Latest cached Sagimet Biosciences Inc. Series A Common Stock (SGMT) revenue for Sep 30, 2023 was $2.0M. Net income was -$6.4M. Statements: https://lician.com/financials/sgmt
How did SGMT revenue change from the prior cached period?
Cached Sagimet Biosciences Inc. Series A Common Stock (SGMT) revenue was unchanged from $2.0M (Jul 31, 2023) to $2.0M (Sep 30, 2023). Statements: https://lician.com/financials/sgmt
What is SGMT's market cap?
Sagimet Biosciences Inc. Series A Common Stock (SGMT) market cap is $403.2M on the latest cached fundamentals snapshot.
What kind of company is SGMT?
Sagimet Biosciences Inc. Series A Common Stock (SGMT) is a biotechnology company listed on NASDAQ.
Where is SGMT stock news listed?
Cached stock news for Sagimet Biosciences Inc. Series A Common Stock (SGMT) is listed at https://lician.com/news/sgmt. Filings: https://lician.com/sec/sgmt
Not investment advice.